Long-term survival with cloacal dysgenesis sequence.
Toshihiro Yanai1, Yasuhisa Urita, Teruyoshi Amagai
1Department of Pediatric Surgery, Ibaraki Children's Hospital, 3-3-1 Futabadai, Mito-city, Ibaraki, 311-4145, Japan. to.yanai@ibaraki-kodomo.com
Pediatric Surgery International
|December 16, 2011
Summary
Cloacal dysgenesis sequence (CDS) is a rare lethal malformation. This report details a rare case of long-term survival to 12 years, highlighting successful surgical interventions.
Area of Science:
- Pediatric Surgery
- Medical Genetics
- Congenital Malformations
Background:
- Cloacal dysgenesis sequence (CDS) is a rare and lethal congenital malformation.
- It involves the abnormal development of the cloaca, leading to severe defects in the urinary, reproductive, and lower gastrointestinal tracts.
- Historically, CDS has been associated with extremely poor prognosis and high mortality.
Observation:
- This case report describes a female patient with CDS who has survived to 12 years of age.
- Fetal intervention included a vesico-amniotic shunt for megabladder secondary to severe urethral obstruction.
- Postnatal management involved cystostomy and colostomy due to the absence of perineal openings for the urethra, vagina, and anus.
Findings:
- The patient underwent multiple complex surgical procedures, including anorectoplasty, creation of an efferent conduit, and colostomy closure at 4 years.
- Further reconstructive surgeries at 11 years included ileovaginoplasty, an ileovesicostomy (Mitrofanoff-type conduit), and labioplasty.
- This represents one of the longest reported survivals for a patient with CDS.
Implications:
- This case demonstrates the potential for long-term survival in CDS patients with timely and aggressive multi-stage surgical management.
- It highlights the importance of fetal interventions and complex postnatal reconstructive surgeries in improving outcomes for rare congenital anomalies.
- Further research into the genetic and developmental mechanisms of CDS may lead to improved diagnostic and therapeutic strategies.

